We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Exiqon and Takara Bio Partner in the Distribution of Products in Asia

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

In addition to this new distribution of products, Takara Bio plans to launch contract research services utilizing Exiqon 's products in Japan on December 10, 2012.

MicroRNAs are single-stranded RNAs that are approximately 18 to 26 nucleotides in length, and play key roles in the regulation of gene expression which is essential for living organisms. miRNA research has received a lot of attention in recent years, and has been strongly promoted in the field of cancer research, stem cell research, developmental biology and neuroscience.

Exiqon has its own proprietary LNA™ (Locked Nucleic Acid) technology which makes it unique and puts it well ahead of its competitors. This technology platform offers global miRNA detection or expression profiling with unmatched specificity and sensitivity.

With the addition of Exiqon's competitive products, Takara Bio will continue to offer a comprehensive range of new and innovative products and services which will enhance the convenience of customers.